Also trades as: CLS.JO (JNB) · $vol 20M

$25.51

-0.70 (-2.67%)

Weekly Expected Move ±6.5%

$22 $24 $26 $27 $29

OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Buy · Power 61 · $3.0B mcap · 117M float · 0.035% daily turnover · Short 65% of daily vol

Revenue

$50.0B +10.1% ▲

5Y CAGR: +7.8%

Gross Profit

$12.7B +19.9% ▲

5Y CAGR: +12.1%

Operating Income

$4.6B +9.4% ▲

5Y CAGR: +10.5%

Net Income

$3.2B +11.2% ▲

5Y CAGR: +10.9%

EPS (Diluted)

$39.32 +64.9% ▲

5Y CAGR: +21.2%

EBITDA

$6.4B +6.8% ▲

5Y CAGR: +10.0%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$37.3B	$39.6B	$41.6B	$45.4B	$50.0B
YoY Growth	+8.7%	+6.0%	+5.1%	+9.2%	+10.1%
Cost of Revenue	$30.1B	$31.2B	$32.3B	$34.8B	$37.3B
Gross Profit	$7.3B	$8.4B	$9.3B	$10.6B	$12.7B
Gross Margin	19.5%	21.3%	22.4%	23.4%	25.5%
R&D Expenses	$57M	$86M	$0	$0	$0
SG&A Expenses	$3.8B	$4.2B	$392M	$6.5B	$438M
Operating Expenses	$4.3B	$4.8B	$5.7B	$6.5B	$8.2B
Operating Income	$2.9B	$3.7B	$3.6B	$4.2B	$4.6B
Operating Margin	7.8%	9.2%	8.7%	9.2%	9.1%
Interest Expense	$220M	$210M	$232M	$355M	$355M
Income Before Tax	$2.6B	$3.6B	$3.5B	$3.9B	$4.3B
Tax Expense	$728M	$1.0B	$934M	$1.1B	$1.2B
Net Income	$1.8B	$2.6B	$2.5B	$2.8B	$3.2B
Net Margin	4.9%	6.7%	6.1%	6.2%	6.3%
EPS (Diluted)	$14.88	$21.60	$20.84	$23.84	$39.32
EBITDA	$4.1B	$5.2B	$5.2B	$6.0B	$6.4B
Shares Outstanding	124M	122M	122M	119M	119M

Line Item	FY2022 Q4	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2
Revenue	$21.7B	$21.3B	$23.2B	$21.8B	$25.3B	$23.2B	$26.8B	$25.4B
Cost of Revenue	$16.4B	$16.2B	$17.5B	$16.7B	$19.0B	$17.6B	$19.3B	$19.0B
Gross Profit	$5.3B	$5.1B	$5.6B	$5.1B	$6.3B	$5.6B	$7.2B	$6.4B
Gross Margin	24.4%	23.7%	24.4%	23.6%	24.8%	24.0%	26.8%	25.0%
R&D Expenses	$43M	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$3.2B	$3.4B	$3.7B	$2.8B	$4.0B	$2.9B	-$2.5B	$4.2B
Operating Expenses	$3.2B	$3.4B	$3.7B	$3.3B	$4.0B	$3.5B	$4.1B	$4.2B
Operating Income	$2.1B	$1.6B	$2.0B	$1.9B	$2.3B	$2.1B	$2.5B	$2.1B
Operating Margin	9.8%	7.7%	8.6%	8.5%	9.1%	9.1%	9.4%	8.4%
Interest Expense	$0	$108M	$123M	$326M	$192M	$61M	$189M	$197M
Income Before Tax	$2.0B	$1.6B	$1.9B	$1.7B	$2.2B	$2.0B	$2.4B	$2.0B
Tax Expense	$541M	$424M	$510M	$468M	$589M	$534M	$647M	$533M
Net Income	$1.4B	$1.2B	$1.4B	$1.3B	$1.6B	$1.4B	$1.8B	$1.5B
Net Margin	6.6%	5.4%	6.0%	5.8%	6.2%	6.2%	6.5%	5.7%
EPS (Diluted)	$11.74	$9.44	$11.40	$10.64	$13.16	$12.06	$14.80	$12.36
EBITDA	$2.8B	$2.4B	$2.8B	$2.8B	$3.2B	$3.0B	$3.5B	$3.1B
Shares Outstanding	122M	122M	122M	119M	119M	119M	119M	117M

CLCGY OTC